ESC LATE BREAKING TRIAL - MADRID, SPAIN

First UK study to confirm that ethnicity matters for hypertension treatment

29 August 2025

 

UK, 29 August 2025: Ground-breaking results from the AIM-HY INFORM trial, presented today at the European Society of Cardiology Congress in Madrid, reinforce the critical importance of personalised medicine in hypertension care. The trial is the first UK study to confirm that ethnicity is a relevant consideration in hypertension drug response, and it does so by comparing within-person responses to three common blood pressure treatments.

DOWNLOAD

View Other News